Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Tobishi reports outstanding selectivity of it's CCK-A antagonist

May 10, 1996

James Black Foundation describes CCK-B/gastrin receptor antagonist

May 10, 1996

Plasmin/kallikrein inhibitors from Hisamitsu

May 3, 1996

Hepagene preliminary phase III results look positive

May 3, 1996

Somatix hepatitis therapy receives patent coverage

May 3, 1996

Dainippon reports anti-H. pylori compounds

April 26, 1996

Tanabe Seiyaku reports CCK-A antagonist for pancreatitis

April 26, 1996

EPC-K for pancreatitis

April 26, 1996

Infergen NDA filed in U.S.

April 26, 1996

Sanwa's SKK-47029 for disorders of gastric emptying

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.